ANL Adlai Nortye Ltd.
Healthcare$11.92+3.11%ClosedMarket Cap: $632.7M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-15.27
P/S
126.54
EV/EBITDA
-19.47
DCF Value
$0.42
FCF Yield
-5.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-714.0%
Net Margin
-710.6%
ROE
-414.0%
ROA
-103.2%
ROIC
-197.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY null | $5.0M | 100.0% | $-35.7M | $-35.5M | $— | — |
| FY null | $0.00 | NaN% | $-52.9M | $-51.9M | $— | — |
| Q2 null | $745.0K | 100.0% | $-14.6M | $-13.8M | $— | — |
| Q1 null | $745.0K | 100.0% | $-14.6M | $-13.8M | $— | — |
| Q4 null | $2.5M | 100.0% | $-17.7M | $-13.2M | $— | — |
| FY null | $0.00 | NaN% | $-72.6M | $-109.2M | $— | — |
| Q3 null | $2.5M | 100.0% | $-17.7M | $-13.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-16.9M | $-63.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-15.3M | $-15.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-19.2M | $-22.1M | $— | — |
| FY null | $0.00 | NaN% | $-67.3M | $-58.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-19.2M | $-22.1M | $— | — |